Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China flag China · Delayed Price · Currency is CNY
55.72
+0.58 (1.05%)
At close: Jun 18, 2026

SHE:301096 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
396.51292.6428.97881.931,2392,013
Trading Asset Securities
608083---
Cash & Short-Term Investments
456.51372.6511.97881.931,2392,013
Cash Growth
-10.99%-27.22%-41.95%-28.81%-38.46%1406.49%
Accounts Receivable
954.7902744.4532.18254.49124.41
Other Receivables
3.879.763.164.14.794.1
Receivables
958.57911.77747.56536.28259.28128.5
Inventory
180.11176.44177.3493.1766.0522.85
Prepaid Expenses
----1.83-
Other Current Assets
103.2291.28108.6196.443.9461.2
Total Current Assets
1,6981,5521,5451,6081,6102,226
Property, Plant & Equipment
1,7421,7771,8321,7411,075566.63
Long-Term Investments
16.4202.5187.78136.8781.125.77
Other Intangible Assets
89.1389.893.4392.0782.3760.79
Long-Term Accounts Receivable
----1.911.95
Long-Term Deferred Tax Assets
37.4336.8735.5548.4353.4122.86
Long-Term Deferred Charges
0.931.081.420.253.9914.41
Other Long-Term Assets
218.0127.0525.843.1421.626.92
Total Assets
3,8023,6863,7213,6692,9302,925
Accounts Payable
105.3248.7841.82130.25167.0312.64
Accrued Expenses
16.1630.9839.973.444.6954.8
Short-Term Debt
518.13510.61360.08369.32-5.01
Current Portion of Long-Term Debt
179.56169.74104.25--220.32
Current Portion of Leases
-0.620.730.388.848.8
Current Income Taxes Payable
2.66-0.035.065.736.17
Current Unearned Revenue
81.9476.06112.4274.0162.6171.17
Other Current Liabilities
2.6983.12110.14193.771.893.79
Total Current Liabilities
906.46919.91769.38846.19290.7472.69
Long-Term Debt
310.01189.51244--40.44
Long-Term Leases
2.52.342.920.93-8.14
Long-Term Unearned Revenue
21.7823.7231.4840.671.45-
Long-Term Deferred Tax Liabilities
----4.320.01
Other Long-Term Liabilities
59.8661.8494.0297.17150.9785.83
Total Liabilities
1,3011,1971,142984.97447.45607.1
Common Stock
109.23109.23109.23108.92108.17108.17
Additional Paid-In Capital
2,1072,1072,1072,1272,0612,026
Retained Earnings
335.91323.09413.49498.68313.24183.98
Treasury Stock
-50-50-50-50--
Comprehensive Income & Other
-0.17-0.18-0.14-0.14--
Total Common Equity
2,5022,4892,5792,6842,4832,318
Minority Interest
-----0.26-0.14
Shareholders' Equity
2,5022,4892,5792,6842,4822,318
Total Liabilities & Equity
3,8023,6863,7213,6692,9302,925
Total Debt
1,010872.82711.99370.648.84282.7
Net Cash (Debt)
-553.69-500.22-200.02511.291,2301,730
Net Cash Growth
----58.43%-28.92%-
Net Cash Per Share
-5.09-4.59-1.864.7211.3421.34
Filing Date Shares Outstanding
108.45108.45108.45108.14108.17108.17
Total Common Shares Outstanding
108.45108.45108.45108.14108.17108.17
Working Capital
791.96632.17776.1761.591,3191,753
Book Value Per Share
23.0722.9523.7824.8222.9521.43
Tangible Book Value
2,4132,3992,4862,5922,4002,257
Tangible Book Value Per Share
22.2522.1222.9223.9722.1920.87
Buildings
-980.29863.44859.97196.19196.14
Machinery
-1,1941,079629.9642.96319.94
Construction In Progress
-66.67206.66448.82546.21104.08